NASH is an advanced form of Non-Alcoholic Fatty Liver Disease (NAFLD).
NAFLD is a type of liver disease that is not caused by alcohol consumption. It is often associated
with risk factors such as obesity, type 2 diabetes, high cholesterol, and high blood pressure. It is
estimated that up to 25% of adults in the U.S. have NAFLD.
NAFLD can progress to NASH, non-alcoholic steatohepatitis. Having NASH means that there is
inflammation and cell damage in the liver. This progression can happen rapidly and can further
progress into cirrhosis and other serious liver conditions. Approximately 20% of people with
NAFLD may progress to NASH.
Many people who have NASH are not aware that they have it. NASH usually develops with few
or no outward symptoms, so it is important to check for it if you have risk factors as explained
above. There are currently no approved drugs to stop or reverse NASH.
The purpose of the Inventiva NATiV3 study is to evaluate an investigational medication as a
potential long-term treatment for people living with NASH who have certain levels of liver
fibrosis (scarring and stiffening of the liver). Study participants may receive the investigational
medication as well as all study-related exams and visits at no charge.
Liver disease of any kind is a very serious medical condition. Therefore, it is important that
researchers find new medications to help people with NASH. This is why we hope you will
send in your information to see if you can participate and help.
|
Please contact us to see if the Inventiva NATiV3 research study may be an option if: |
|||||||||
|
* You have been diagnosed with NASH; or, |
|||||||||
|
* You have one or more of the following risk factors for NASH:
|
|||||||||
This is not a complete list of requirements to participate. Please provide us with your contact
information so we can discuss these and additional requirements with you.
Your contact information will remain confidential and will only be used to contact you regarding
participation in our research study.
While participation in a clinical trial, also called a research study, is voluntary, you may be compensated for your time and travel. Compensation will be discussed by the staff at the research center.
If you are interested in participating or just wish to learn more, please provide your contact information. We will contact you within two business days after your submission.
Doctors and scientists are constantly discovering new medications and devices that may help prevent, detect, diagnose, control, and treat illnesses. A clinical trial or research study is a scientific study that tests these new discoveries. Clinical trials depend upon the participation of volunteers.
There is no guarantee that subjects will receive any benefit from participating in this study. However, this research study may yield new information that could benefit people in the future by helping to answer questions about the effectiveness and safety of the study treatment.
Participation in a research study is completely voluntary. In all research studies, qualified potential participants are first informed about the research study in detail. After receiving this information, all participants must give their consent in writing to proceed. Some research studies involve more tests and doctor visits than the participant would normally have for an illness or condition.
Health Insurance is NOT required to participate.
You will not be charged for the study medication, study-related procedures and tests, or study
visits.
Before participating in a trial volunteers must meet specific requirements. These requirements are based on various factors, such as your age, medical history, current health status, current medications, and allergies. The circumstances that allow one to participate are called Inclusion Criteria and those that prevent participation are called Exclusion Criteria. These requirements are used to ensure the accuracy of the trial as well as the safety of all participants. We will not know whether you satisfy all study requirements until we speak with you and, if appropriate, complete a screening assessment at our facilities.
ObjectiveHealth research network partners with leading physicians to given them the tools
needed to integrate clinical trials into their practice. As a result, patients gain access to trials
within their community. As part of a collaborative program, we are offering you the extra care
you need in an environment designed to provide you with the best healthcare information,
support, and emerging treatment options.
ObjectiveHealth research network conducts studies at the following locations:
1 Independence Plaza, Suite 810
Homewood, AL 35209
(MAP)
1041 Balch Rd, Suite 300
Madison, AL 35758
(MAP)
1500 N Museum Rd, Suite 100
Conway, AR 72032
(MAP)
8924 Kanis Rd.
Little Rock, AR, 72205
(MAP)
10030 Edison Square Drive NW, Suite 204
Concord, NC 28027
(MAP)
